GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Blonder Tongue Laboratories Inc (OTCPK:BDRL) » Definitions » EBIT

Blonder Tongue Laboratories (Blonder Tongue Laboratories) EBIT : $-1.24 Mil (TTM As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Blonder Tongue Laboratories EBIT?

Blonder Tongue Laboratories's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $-0.32 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.24 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Blonder Tongue Laboratories's annualized ROC % for the quarter that ended in Dec. 2023 was -12.63%. Blonder Tongue Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -17.79%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Blonder Tongue Laboratories's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -11.12%.


Blonder Tongue Laboratories EBIT Historical Data

The historical data trend for Blonder Tongue Laboratories's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blonder Tongue Laboratories EBIT Chart

Blonder Tongue Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.47 -7.11 0.61 -2.13 -1.24

Blonder Tongue Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 -0.29 -0.51 -0.13 -0.32

Competitive Comparison of Blonder Tongue Laboratories's EBIT

For the Communication Equipment subindustry, Blonder Tongue Laboratories's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blonder Tongue Laboratories's EV-to-EBIT Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Blonder Tongue Laboratories's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Blonder Tongue Laboratories's EV-to-EBIT falls into.



Blonder Tongue Laboratories EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blonder Tongue Laboratories  (OTCPK:BDRL) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Blonder Tongue Laboratories's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-1.356 * ( 1 - -2.24% )/( (11.232 + 10.73)/ 2 )
=-1.3863744/10.981
=-12.63 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Blonder Tongue Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-1.276/( ( (5.052 + max(2.274, 0)) + (4.838 + max(2.185, 0)) )/ 2 )
=-1.276/( ( 7.326 + 7.023 )/ 2 )
=-1.276/7.1745
=-17.79 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.576 + 2.942 + 0.549) - (2.288 + 0 + 0.505)
=2.274

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.538 + 2.866 + 0.383) - (2.234 + 0 + 0.368)
=2.185

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Blonder Tongue Laboratories's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=-1.238/11.131
=-11.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blonder Tongue Laboratories EBIT Related Terms

Thank you for viewing the detailed overview of Blonder Tongue Laboratories's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Blonder Tongue Laboratories (Blonder Tongue Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
One Jake Brown Road, Old Bridge, NJ, USA, 08857
Blonder Tongue Laboratories Inc is a technology development and manufacturing company that provides television signal encoding, transcoding, digital transport, and broadband product solutions in the United States. The company serves the multi-dwelling unit market, the lodging/hospitality market, and the institutional market, including hospitals, prisons, and schools, throughout the United States and Canada. The Company's revenues are derived from customers in the continental United States; it also derives some revenues from customers in other geographical markets like Canada and to a more limited extent, in developing countries.
Executives
Williams James H /nj/ director C/O BLONDER TONGUE LABORATORIES INC, ONE JAKE BROWN RD, OLD BRIDGE NJ 08857
Palle Robert J Jr director, 10 percent owner, officer: President and COO C/O BLONDER TONGUE LABORATORIES INC, ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857
Eric S Skolnik officer: Senior Vice President - CFO C/O BLONDER TONGUE LABORATORIES INC, ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857
John E Burke director 1540 BARDSEY LANE, LOWER GWYNEDD PA 19002
Anthony J Bruno director C/O BLONDER TONGUE LABORATORIES, INC., ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857
Cavalry Fund I Lp 10 percent owner 82 EAST ALLENDALE ROAD, SUITE 5B, SADDLE RIVER NJ 07458
Michael Hawkey director 2160 GOLD STREET, SAN JOSE CA 95002
Rick E Briggs director C/O BLONDER TONGUE LABORATORIES, INC., ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857
Edward Rowland Grauch officer: CEO & President 3208 HIGHWAY 98, MEXICO BEACH FL 32456
Jeffrey W Smith officer: Vice President - Sales C/O BLONDER TONGUE LABORATORIES, INC., ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857
Ronald Vincent Alterio officer: VP-Engineering, CTO C/O BLONDER TONGUE LABORATORIES, ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857
Gary P Scharmett director
Steven L Shea director C/O BLONDER TONGUE LABORATORIES, INC., ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857
Stephen K Necessary director
Bruce A Gureck officer: Exec VP/COO 4671 BOCAIRE BLVD, BOCA RATON FL 33487